Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Qiagen NV    QGEN   NL0000240000

QIAGEN NV (QGEN)

Delayed Quote. Delayed  - 05/25 09:59:59 pm
21.67 USD   +2.90%
05/25 QIAGEN NV : Partners to Develop Predictive Tests in Oncology
05/23 QIAGEN NV : Bioinformatics continues to set the standard with Heredi..
05/19 QIAGEN NV : Extends Tender Offer Period for Acquisition of Exiqon A/..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Sales1 3061 3451 2811 3331 4181 513
Operating income (EBITDA)404394467421458490
Operating profit (EBIT)318313315304338373
Pre-Tax Profit (EBT)37,3-----
Net income69,1117127152194227
P/E ratio82,148,951,237,630,123,1
EPS ( $ )0,290,480,540,580,720,94
Dividend per Share ( $ )-----0,12
Yield-----0,55%
Reference price ( $ )23.8123.4627.6521.6721.6721.67
Announcement Date01/29/2014
06:00am
01/29/2015
03:06pm
02/02/2016
11:46pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Debt465595639453216115
Finance------
Operating income (EBITDA)404394467421458490
Leverage
(Debt/EBITDA)
1,15x1,51x1,37x1,08x0,47x0,24x
Capital Expenditure84,586,697,8100108109
Book Value Per Share (BVPS)11,6 $11,4 $11,0 $11,6 $12,3 $12,9 $
Cash Flow per Share1,07 $1,19 $1,34 $1,55 $1,67 $1,79 $
Announcement Date01/29/2014
06:00am
01/29/2015
03:06pm
02/02/2016
11:46pm
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 5 194 M$ -
Entreprise Value (EV) 5 647 M$ 5 410 M$
Valuation 2016e 2017e
P/E ratio (Price / EPS) 37,6x 30,1x
Capitalization / Revenue 3,90x 3,66x
EV / Revenue 4,24x 3,82x
EV / EBITDA 13,4x 11,8x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 1,87x 1,77x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 22,8% 23,8%
operating Leverage (Delta EBIT / Delta Sales) - 1,72x
Net Margin (Net Profit / Revenue) 11,4% 13,7%
ROA (Net Profit / Asset) 5,43% 6,19%
ROE (Net Profit / Equities) 8,65% 9,26%
Rate of Dividend - -
Balance Sheet Analysis 2016e 2017e
CAPEX / Sales   7,53% 7,59%
Cash Flow / Sales 27,2% 27,6%
Capital Intensity (Assets / Sales) 2,11x 2,22x
Financial Leverage (Net Debt / EBITDA) 1,08x 0,47x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend